FDA inspection
Jiangsu Baozong & Baoda Pharmachem Co., Ltd.: FDA inspection ending Aug 10, 2018
FDA inspection 1064318 · Voluntary Action Indicated (VAI) · Nantong
Key facts
| Inspection ID | 1064318 |
|---|---|
| Firm | Jiangsu Baozong & Baoda Pharmachem Co., Ltd. |
| FEI number | 3009160668 |
| Address | NO. 10 Yuejiang Road, Changjiang Town |
| City | Nantong |
| Country | China |
| Fiscal year | 2018 |
| Inspection end date | Aug 10, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data